{
    "Trade/Device Name(s)": [
        "IntelliSep test",
        "Cytovale System"
    ],
    "Submitter Information": "Cytovale, Inc.",
    "510(k) Number": "K220991",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162827"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QUT"
    ],
    "Summary Letter Date": "March 31, 2022",
    "Summary Letter Received Date": "April 4, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3215"
    ],
    "Regulation Name(s)": [
        "Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis"
    ],
    "Analyte Class(es)": [
        "immunology",
        "hematology"
    ],
    "Analyte(s)": [
        "Leukocyte biophysical properties"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Cytovale System"
    ],
    "Method(s)/Technology(ies)": [
        "Microfluidic deformability cytometry"
    ],
    "Methodologies": [
        "Deformability cytometry",
        "Cellular biophysical property analysis"
    ],
    "Submission Type(s)": [
        "Test",
        "Analyzer",
        "Reagent",
        "Cartridge",
        "Tube",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Cytovale IntelliSep test using microfluidic deformability cytometry on leukocytes to aid in early detection of sepsis in adults in the Emergency Department.",
    "Indications for Use Summary": "Aids in early detection of sepsis with organ dysfunction in adult patients with signs and symptoms of infection presenting to the Emergency Department, by assessing cellular host response via deformability cytometry of leukocyte biophysical properties in EDTA whole blood; intended to be used with clinical assessments and laboratory findings.",
    "fda_folder": "Microbiology"
}